324 related articles for article (PubMed ID: 24750361)
41. Preprocedural High-Sensitivity C-Reactive Protein Predicts Long-Term Outcome of Percutaneous Coronary Intervention.
Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Shimada K; Suwa S; Daida H
Circ J; 2016 Dec; 81(1):90-95. PubMed ID: 27867158
[TBL] [Abstract][Full Text] [Related]
42. The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery disease patients.
Fabijanić D; Banić M; Kardum D; Sutlić Z; Simunić M; Bonacin D; Romić Z; Petricusić L; Kujundzić M
Med Sci Monit; 2009 Feb; 15(2):CR45-50. PubMed ID: 19179966
[TBL] [Abstract][Full Text] [Related]
43. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
Koc M; Karaarslan O; Abali G; Batur MK
Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
[TBL] [Abstract][Full Text] [Related]
44. High-sensitivity C-reactive protein is an independent marker of abnormal coronary vasoreactivity in patients with non-obstructive coronary artery disease.
Sara JDS; Prasad M; Zhang M; Lennon RJ; Herrmann J; Lerman LO; Lerman A
Am Heart J; 2017 Aug; 190():1-11. PubMed ID: 28760202
[TBL] [Abstract][Full Text] [Related]
45. Long-Term Predictive Value of High-Sensitivity C-Reactive Protein for Cancer Mortality in Patients Undergoing Percutaneous Coronary Intervention.
Endo H; Dohi T; Funamizu T; Shitara J; Wada H; Doi S; Naito R; Konishi H; Ogita M; Iwata H; Kasai T; Okazaki S; Isoda K; Shimada K; Miyauchi K; Daida H
Circ J; 2019 Feb; 83(3):630-636. PubMed ID: 30541988
[TBL] [Abstract][Full Text] [Related]
46. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease.
Ramadan MM; Kodama M; Mitsuma W; Ito M; Kashimura T; Ikrar T; Hirono S; Okura Y; Aizawa Y
Am J Cardiol; 2006 Oct; 98(7):915-7. PubMed ID: 16996873
[TBL] [Abstract][Full Text] [Related]
47. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
[TBL] [Abstract][Full Text] [Related]
48. Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials.
Iijima R; Byrne RA; Ndrepepa G; Braun S; Mehilli J; Berger PB; Schömig A; Kastrati A
Heart; 2009 Feb; 95(2):107-12. PubMed ID: 18801777
[TBL] [Abstract][Full Text] [Related]
49. The impact of previous revascularization on clinical outcomes in patients undergoing primary percutaneous coronary intervention.
Bench TJ; Parikh PB; Jeremias A; Brener SJ; Naidu SS; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
J Invasive Cardiol; 2013 Apr; 25(4):166-9. PubMed ID: 23549488
[TBL] [Abstract][Full Text] [Related]
50. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
51. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
[TBL] [Abstract][Full Text] [Related]
52. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
[TBL] [Abstract][Full Text] [Related]
53. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
[TBL] [Abstract][Full Text] [Related]
54. The level of hs-CRP in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment.
Ozbay Y; Akbulut M; Balin M; Kayancicek H; Baydas A; Korkmaz H
Mediators Inflamm; 2007; 2007():89649. PubMed ID: 17497040
[TBL] [Abstract][Full Text] [Related]
55. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
[TBL] [Abstract][Full Text] [Related]
56. [The relationship between coronary collateral circulation and blood high-sensitivity C-reactive protein levels].
Kadı H; Ceyhan K; Karayakalı M; Koç F; Celik A; Onalan O
Turk Kardiyol Dern Ars; 2011 Jan; 39(1):23-8. PubMed ID: 21358227
[TBL] [Abstract][Full Text] [Related]
57. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
[TBL] [Abstract][Full Text] [Related]
58. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation.
Akboga MK; Canpolat U; Sahinarslan A; Alsancak Y; Nurkoc S; Aras D; Aydogdu S; Abaci A
Atherosclerosis; 2015 May; 240(1):110-4. PubMed ID: 25770689
[TBL] [Abstract][Full Text] [Related]
59. Oxidative stress and inflammation due to peripheral polymorphonuclear leukocytes after coronary angiography vs percutaneous coronary intervention.
Farah R; Shurtz-Swirski R; Bolotin Y; Brezins M
Minerva Cardioangiol; 2008 Apr; 56(2):189-95. PubMed ID: 18319697
[TBL] [Abstract][Full Text] [Related]
60. Independent and joint effects of high-sensitivity c-reactive protein and hypoalbuminemia on long-term all-cause mortality among coronary artery disease: a prospective and multicenter cohort study.
Huang H; Yu Y; Chen L; Chen S; Tang R; Li Q; Wei W; Bao K; Huang Z; Lai W; Wang B; Tan N; Chen J; Liu J; Liu Y
BMC Cardiovasc Disord; 2021 Dec; 21(1):613. PubMed ID: 34961476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
